EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors

NCT03481868 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukemia (CML)
Chronic Phase

Interventions

BIOLOGICAL: Collection of blood and bone marrow

Sponsor

University Hospital, Clermont-Ferrand

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]